JNJ, ABBV Growth Paths Diverge
Johnson & Johnson and AbbVie pursue different growth strategies, impacting investor expectations. Pharmaceutical sector implications.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.